Position history for BAKER BROS. ADVISORS LP's holdings in TAYSHA GENE THERAPIES INC
BAKER BROS. ADVISORS LP holds 4M shares of TSHA (TAYSHA GENE THERAPIES INC), worth $22M as of 2025-Q4. TSHA represents 0.1% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$22M
Current Shares
4M
Total Value Change
+$13.1M
Total Shares Change
0
Other major holders of TSHA: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, BlackRock, Inc., MORGAN STANLEY
Unchanged |
| 4M |
0.0% |
| $22M |
| 0.1% |
| $5.66 |
0 |
| 2025-Q3 | Unchanged | 4M | 0.0% | $13.1M | 0.1% | $3.16 | 0 |
| 2025-Q2 | Unchanged | 4M | 0.0% | $9.3M | 0.1% | $2.38 | 0 |
| 2025-Q1 | Unchanged | 4M | 0.0% | $5.6M | 0.1% | $1.93 | 0 |
| 2024-Q4 | Unchanged | 4M | 0.0% | $6.9M | 0.1% | $1.73 | 0 |
| 2024-Q3 | Unchanged | 4M | 0.0% | $8M | 0.1% | $2.07 | 0 |
| 2024-Q2 | Unchanged | 4M | 0.0% | $9M | 0.1% | $2.24 | 0 |